108 related articles for article (PubMed ID: 4239673)
1. [Diabetic retinopathy. Therapeutic attempt].
Rousselie F
Arch Ophtalmol Rev Gen Ophtalmol; 1969 Feb; 29(2):107-14. PubMed ID: 4239673
[No Abstract] [Full Text] [Related]
2. [Indications and limits of photo-coagulation in the treatment of diabetic retinopathy].
Guillaumat L
Bibl Ophthalmol; 1968; 76():154-9. PubMed ID: 5674836
[No Abstract] [Full Text] [Related]
3. [Risk factors in the loss of vision in diabetic retinopathy treated by xenon photocoagulation].
Zygulska-Machowa H; Mirkiewicz-Sieradzka B
Klin Oczna; 1983 Apr; 85(4):167-8. PubMed ID: 6195393
[No Abstract] [Full Text] [Related]
4. [Photographic control of the evolution of diabetic retinopathy (hemorrhagic component) during a medical treatment].
Bruni B; Della Valle A
Minerva Med; 1972 Jun; 63(48):2671-89. PubMed ID: 5040921
[No Abstract] [Full Text] [Related]
5. Diabetic retinopathy and diabetic papillopathy.
Barbera LG; Weiss MJ; Hofeldt AJ
Semin Neurol; 1996 Jun; 16(2):179-85. PubMed ID: 8987132
[No Abstract] [Full Text] [Related]
6. [Peripheral retinal hemorrhage in the long-term insulin-dependent diabetic with minor retinopathy of the fundus].
Roy MS; McCulloch JC
Bull Mem Soc Fr Ophtalmol; 1980; 92():332-5. PubMed ID: 7225701
[No Abstract] [Full Text] [Related]
7. [Epidemiology of diabetic retinopathy].
Ayed S; Jeddi A; Daghfous F; Ben Osman N; Sebai L
Tunis Med; 1993 Mar; 71(3):141-4. PubMed ID: 8351727
[No Abstract] [Full Text] [Related]
8. [Indications and limits of photocoagulation in the treatment of diabetic retinopathy].
Guillaumat L; Esta A
Ann Ocul (Paris); 1968 May; 201(5):481-92. PubMed ID: 5703981
[No Abstract] [Full Text] [Related]
9. [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)].
Freyler H; Sehorst W
Klin Monbl Augenheilkd; 1974 Feb; 164(2):246-51. PubMed ID: 4842139
[No Abstract] [Full Text] [Related]
10. [Value of tetrahydroxy flavan-diol in ophthalmology, especially in chronic retinopathy (40 cases)].
Magnard G; Franck JP; Dorne PA
Lyon Med; 1970 Jan; 223(4):259-63. PubMed ID: 5435320
[No Abstract] [Full Text] [Related]
11. Diabetic retinopathy and salicylates.
Carroll WW; Geeraets WJ
Ann Ophthalmol; 1972 Dec; 4(12):1019-45. PubMed ID: 4640731
[No Abstract] [Full Text] [Related]
12. Diabetic retinopathy.
Wilkinson CP
J Okla State Med Assoc; 1972 Oct; 65(10):399-404. PubMed ID: 5077204
[No Abstract] [Full Text] [Related]
13. Progress report on cases of proliferative diabetic retinopathy treated with light coagulation. (Four-year follow-up).
Guinan P
Trans Ophthalmol Soc U K (1962); 1969; 88():741-9. PubMed ID: 5272290
[No Abstract] [Full Text] [Related]
14. Natural history of diabetic retinopathy.
Goldberg MF
Isr J Med Sci; 1972; 8(8):1311-5. PubMed ID: 4647779
[No Abstract] [Full Text] [Related]
15. The epidemiology of diabetic microangiopathy.
Caird FI
Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():240-8. PubMed ID: 5146907
[No Abstract] [Full Text] [Related]
16. Treatment for diabetic retinopathy.
Drug Ther Bull; 1972 Oct; 10(22):85-7. PubMed ID: 4676365
[No Abstract] [Full Text] [Related]
17. [Use of conjugated estrogens in diabetic retinopathy].
Németh L
Klin Monbl Augenheilkd; 1969 Oct; 155(4):543-8. PubMed ID: 4315571
[No Abstract] [Full Text] [Related]
18. Blindness due to diabetes: population-based age- and sex-specific incidence rates.
Icks A; Trautner C; Haastert B; Berger M; Giani G
Diabet Med; 1997 Jul; 14(7):571-5. PubMed ID: 9223395
[TBL] [Abstract][Full Text] [Related]
19. [Study of the action of a vascular protector on diabetic vascular fragility].
Nove-Josserand G; Chirat P; Bussy L; Bonnamour C; Peaud PY; Ortonne JP; Gaillarde B; Plauchu M
Lyon Med; 1971 Dec; 226(19):791-4. PubMed ID: 5159275
[No Abstract] [Full Text] [Related]
20. Caclium dobesilate in diabetic retinopathy.
Sévin R; Cuendet JF
Ophthalmologica; 1969; 159(1):126-35. PubMed ID: 5369367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
